Biomodulation of transcriptional factor NF-κB by ionizing radiation;Biomodulation du facteur de transcription NF-κB par les radiations ionisantes

Cancer/Radiotherapie

Volumn 8, Issue 5, 2004, Pages 315-321

  Magne N ^a   Didelot, C ^b   Toillon, R A ^a   Van Houtte, P ^a   Peyron, J F ^c  

^a JULES BORDET INSTITUTE   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c INSERM   (France)

Author keywords

Apoptose; Apoptosis; Cell survival; NF B; Oncologie; Oncology; Radiotherapy; Radioth rapie; Survie cellulaire

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN LIGHT CHAIN;

APOPTOSIS; CANCER RADIOTHERAPY; CELL PROLIFERATION; HUMAN; IMMUNOMODULATION; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; REVIEW; TRANSCRIPTION INITIATION;

EID: 9244237572     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2004.08.002     Document Type: Short Survey

References (57)

1. S. Amit, and Y. Ben-Neriah NF-κB activation in cancer: a challenge for ubiquitination- and protasome-based therapeutic approach Sem. Cancer Biol. 13 2003 15 28
2. P.A. Baeuerle, and D. Baltimore NF-kappa B: ten years after Cell 87 1996 13 20
3. A.S. Baldwin Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights Annu. Rev. Immunol. 14 1996 649 693
4. M. Barkett, and T.D. Gilmore Control of apoptosis by Rel/NF-kappaB transcription factors Oncogene 18 1999 6910 6924
5. P.J. Barnes, and M. Karin Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases N. Engl. J. Med. 336 1997 1066 1071
6. P.J. Barnes Nuclear factor-kappa B Int. J. Biochem. Cell Biol. 29 1997 867 870
7. R.E. Bellas, and G.E. Sonenshein Nuclear factor kappaB cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function Cell Growth Differ. 10 1999 287 294
8. M. Bentires-Alj, V. Barbu, M. Fillet, A. Chariot, B. Relic, N. Jacobs, and J. Gielen NF-kappaB transcription factors induces drug resistance through MDR1 expression in cancer cells Oncogene 22 2003 90 97
9. M. Bentires-Alj, E. Dejardin, P. Viatour, C. Van Lint, B. Froesch, and J.C. Reed Inhibition of the NF-kappaB transcription factor increases Bax expression in cancer cell lines Oncogene 20 2001 2805 2813
10. M. Bentires-Alj, A.C. Hellin, M. Ameyar, S. Chouaib, M.P. Merville, and V. Bours Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs Cancer Res. 59 1999 811 815
11. V. Bottero, V. Busuttil, A. Loubat, N. Magń, J.L. Fischel, and G. Milano Activation of nuclear factor kappaB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells Cancer Res. 61 2001 7785 7791
12. V. Bours, G. Bonizzi, M. Bentires-Alj, F. Bureau, J. Piette, and P. Lekeux NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment Toxicology 153 2000 27 38
13. C.M. Bradbury, S. Markovina, S.J. Wei, L.M. Rene, I. Zoberi, and N. Horikoshi Indomethacin-induced radiosensitiation and inhibition of ionizing radiation-induced NF-κB activation in HeLa cells occur via a mechanism involving p38 MAP kinase Cancer Res. 61 2001 7689 7696
14. V. Busuttil, V. Bottero, C. Frelin, V. Imbert, J.F. Ricci, and P. Auberger Blocking NF-kappa B activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector Oncogene 21 2002 3213 3224
15. M.M. Chaturvedi, A. Kumar, B.G. Darnay, G.B. Chainy, S. Agarwal, and B.B. Aggarwal Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation J. Biol. Chem. 272 1997 30129 30134
16. X. Chen, B. Shen, L. Xia, A. Khaletzkiy, D. Chu, and J.Y. Wong Activation of nuclear factor kappab in radioresistance of TP53-inactive human keratinocytes Cancer Res. 62 2002 1213 1221
17. J.C. Cusack, R. Liu, and A.S. Baldwin NF-κB and chemoresistance: potentiation of cancer chemotherapy via inhibition of NF-κB Drug Resist. Updat. 2 1999 271 273
18. C. Didelot, M. Barberi-Heyob, A. Bianchi, P. Becuwe, J.F. Mirjolet, and M. Dauca Constitutive NF-kappaB activity influences basal apoptosis and radiosensitivity of head-and-neck carcinoma cell lines Int. J. Radiat. Oncol. Biol. Phys. 51 2001 1354 1360
19. L.J. Egan, L. Eckmann, F.R. Greten, S. Chae, Z.W. Li, and G.M. Myhre I{kappa}B-kinase{beta}-dependent NF-{kappa}B activation provides radioprotection to the intestinal epithelium Proc Natl Acad. Sci USA 101 2004 2452 2457
20. J.C. Epinat, and T.D. Gilmore Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway Oncogene 18 1999 6896 6909
21. S.P. Ethier Signal transduction pathways: the molecular basis for targeted therapies Semin. Radiat. Oncol. 12 2002 3 10
22. G. Ghosh, G. Van Duyne, S. Ghosh, and P.B. Sigler Structure of NF-kappa B p50 homodimer bound to a kappa B site Nature 373 1995 303 310
23. V. Imbert, R.A. Rupec, A. Livolsi, H.L. Pahl, E.B. Traenckner, and C. Mueller-Dieckmann Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha Cell 86 1996 787 798
24. M. Iwanaga, K. Mori, T. Iida, Y. Urata, T. Matsuo, and A. Yasunaga Nuclear factor kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells Free Radic. Biol. Med. 24 1998 1256 1268
25. M. Jung, and A. Dritschilo NF-kappa B signaling pathway as a target for human tumor radiosensitization Semin. Radiat. Oncol. 11 2001 346 351
26. M. Karin The beginning of the end: IκB kinase (IKK) and NF-κB activation J. Biol. Chem. 274 1999 27339 273342
27. T. Kato, D.C. Duffey, F.G. Ondrey, G. Dong, Z. Chen, and J.A. Cook Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB Head Neck 22 2000 748 759
28. K. Kimura, C. Bowen, S. Spiegel, and E.P. Gelmann Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis Cancer Res. 59 1999 1606 1614
29. E. Kopp, and S. Ghosh Inhibition of NF-kappa B by sodium salicylate and aspirin Science 265 1994 956 959
30. E.B. Kopp, and S. Ghosh NF-kappa B and rel proteins in innate immunity Adv. Immunol. 58 1995 1 27
31. J.F. Kurland, and R.E. Meyn Protease inhibitors restore radiation-induced apoptosis to Bcl-2-expressing lymphoma cells Int. J. Cancer 96 2001 327 333
32. L. Li, M. Story, and R.J. Legerski Cellular responses to ionizing radiation damage Int. J. Radiat. Oncol. Biol. Phys. 49 2001 1157 1162
33. P.F. Lindholm, J. Bub, S. Kaul, V.B. Shidman, and A. Kajdacsy-Balla The role of constitutive NF-kappaB activity in PC-3 human prostate cancer cell invasive behavior Clin Exp Metastasis 18 2000 471 479
34. R.L. Meighan-Mantha, A.T. Riegel, S. Suy, V. Harris, F.H. Wang, and C. Lozalo Ionizing radiation stimulates octamer factor DNA binding activity in human carcinoma cells Mol. Cell. Biochem. 199 1999 209 215
35. C.W. Muller, and S.C. Harrison The structure of the NF-kappa B p50: DNA-complex: a starting point for analyzing the Rel family FEBS Lett. 369 1995 113 117
36. M. Nakai, Z. Qin, Y. Wang, and T.N. Chase NMDA and non-NMDA receptor-stimualted IkappaB-alpha degradation: differential effects of the caspase-3 inhibitor DEVD.CHO, ethanol and free radical scavenger OPC-14117 Brain Res. 859 2000 207 216
37. H. Nakayama, T. Ikebe, M. Beppu, and K. Shirasuna High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity Cancer 92 2001 3037 3044
38. R.Z. Orlowski, and A.S. Baldwin Jr. NF-kappaB as a therapeutic target in cancer Trends Mol. Med. 8 2002 385 389
39. R.Z. Orlowski, and E.C. Dees The role of the ubiquitination-proteasome pathway in breast cancer: applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer Breast Cancer Res. 5 2003 1 7
40. H.L. Pahl Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 18 1999 6853 6866
41. F. Pajonk, K. Pajonk, and W.H. McBride Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition Int J Radiat Oncol Biol Phys 47 2000 1025 1032
42. F. Pajonk, K. Pajonk, and W.H. McBride Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells J. Natl. Cancer Inst. 91 1999 1956 1960
43. U. Raju, G.J. Gumin, and P.J. Tofilon NF kappa B activity and target gene expression in the rat brain after one and two exposures to ionizing radiation Radiat. Oncol. Investig. 7 1999 145 152
44. R. Ravi, A. Bedi, E.J. Fuchs, and A. Bedi CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB Cancer Res. 58 1998 882 886
45. J.S. Russel, U. Raju, G.J. Gumin, F.F. Lang, D.R. Wilson, and T. Huet Inhibition of radiation-induced nuclear factor-kappaB activation by an anti-Ras single-chain antibody fragment: lack of involvement in radiosensitization Cancer Res. 62 2002 2318 2326
46. J.S. Russel, and P.J. Tofilon Radiation-induced activation of Nuclear Factor-κB involves selective degradation of plasma membrane-associated IκBα Mol. Biol. Cell. 13 2002 3431 3440
47. S.M. Russo, J.E. Tepper, A.S. Baldwin Jr., R. Liu, J. Adams, and P. Elliott Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB Int. J. Radiat. Oncol. Biol. Phys. 50 2001 183 193
48. R. Schreck, P. Rieber, and P.A. Baeuerle Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 EMBO J. 10 1991 2247 2258
49. U. Siebenlist, G. Franzoso, and K. Brown Structure, regulation and function of NF-kappa B Annu. Rev. Cell Biol. 10 1994 405 455
50. N. Sirvent, V. Imbert, C. Frelin, E. Griessinger, and J.F. Peyron Fighting cancer via NF-kappa B inhibition Arch. Pediatr. 10 2003 632 634
51. A.S. Smirnov, A.S. Ruzov, A.V. Budanov, A.V. Prokhortchouk, A.V. Ivanov, and E.B. Prokhotchouk High constitutive level of NF-kappaB is crucial for viability of adenocarcinoma cells Cell Death. Differ. 8 2001 621 630
52. C.Y. Wang, M.W. Mayo, and A.S. Baldwin Jr. TNF- and cancer therapy-induced apoptosis:: potentiation by inhibition of NF-kappaB Science 274 1996 784 787
53. D. Wang, and A.S. Baldwin Jr. Activation of nuclear factor-kappaB- dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529 J. Biol. Chem. 273 1998 29411 29416
54. N. Yamagishi, J. Miyakoshi, and H. Takebe Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells Int. J. Radiat. Biol. 72 1997 157 162
55. A. Yaron, H. Gonen, I. Alkalay, A. Hatzubai, S. Jung, and S. Beyth Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase EMBO J. 16 1997 6486 6494
56. G.L. Yount, G. Afshar, S. Ries, M. Korn, N. Shalev, and D. Basila Transcriptional activation of TRADD mediates p53-independent radiation-induced apotosis of glioma cells Oncogene 20 2001 2826 2835
57. D. Zhou, S.A. Brown, T. Yu, G. Chen, S. Barve, and B.C. Kang A high dose of ionizing radiation induces tissue-specific activation of nuclear factor-kappaB in vivo Radiat. Res. 151 1999 703 709